Can anyone explain Kevetrin's mechanism of action depending on p53 status?

I found conflicting results about use of kevetrin in tumors without wild-type p53. What if tumors carry a partial deficiency allele, such as p.S106R and a deletion of the second allele?

04 April 2015 1,222 0 View